Contineum Therapeutics In... (CTNM)
12.89
0.12 (0.94%)
At close: Jan 15, 2025, 3:59 PM
12.96
0.54%
After-hours Jan 15, 2025, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 |
| Cash & Equivalents | 15.53M | 5.57M | 4.63M |
| Short-Term Investments | 109.66M | 41.67M | 64.37M |
| Long-Term Investments | n/a | n/a | n/a |
| Other Long-Term Assets | 1.28M | 129.00K | 97.00K |
| Receivables | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a |
| Other Current Assets | 2.52M | 1.15M | 775.00K |
| Total Current Assets | 127.71M | 48.39M | 69.78M |
| Property-Plant & Equipment | 1.40M | 2.12M | 642.00K |
| Goodwill & Intangibles | n/a | n/a | n/a |
| Total Long-Term Assets | 2.68M | 2.24M | 739.00K |
| Total Assets | 130.39M | 50.64M | 70.52M |
| Account Payables | 635.00K | 430.00K | 660.00K |
| Deferred Revenue | n/a | n/a | n/a |
| Short-Term Debt | 464.00K | 5.06M | 1.25M |
| Other Current Liabilities | 4.38M | 2.06M | 1.76M |
| Total Current Liabilities | 5.48M | 7.55M | 3.67M |
| Long-Term Debt | 192.73M | 133.27M | 3.66M |
| Other Long-Term Liabilities | 110.00K | 3.02M | 134.08M |
| Total Long-Term Liabilities | 192.84M | 136.30M | 137.74M |
| Total Liabilities | 198.32M | 143.85M | 141.41M |
| Total Debt | 193.19M | 138.33M | 4.91M |
| Common Stock | 2.00K | 12.00K | 12.00K |
| Retained Earnings | -75.14M | -97.86M | -73.61M |
| Comprehensive Income | 108.00K | -76.00K | -35.00K |
| Shareholders Equity | -67.94M | -93.21M | -70.89M |
| Total Investments | 109.66M | 41.67M | 64.37M |